索宝蛋白
(603231)
| 流通市值：16.94亿 | | | 总市值：30.52亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 487,722,648.24 | 1,748,098,617.55 | 1,240,274,258.89 | 773,865,920.48 |
| 营业总成本 | 452,399,406.08 | 1,539,225,328.77 | 1,075,039,263.85 | 666,429,394.26 |
| 其他经营收益 | | | | |
| 营业利润 | 37,575,493.64 | 227,041,819.49 | 177,049,720.64 | 116,846,479.54 |
| 利润总额 | 37,562,502.66 | 223,595,718.48 | 174,639,066.94 | 116,668,681.8 |
| 净利润 | 31,497,538.27 | 189,716,351.28 | 146,687,897.41 | 97,432,394.07 |
| 每股收益 | | | | |
| 其他综合收益 | -8,507.93 | 11,335.77 | 21,391.58 | 31,626.37 |
| 综合收益总额 | 31,489,030.34 | 189,727,687.05 | 146,709,288.99 | 97,464,020.44 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,353,235,871.6 | 1,360,104,211.35 | 1,293,106,653.41 | 1,259,132,882.68 |
| 非流动资产: | | | | |
| 非流动资产合计 | 912,382,167.87 | 909,110,197.85 | 880,725,346.47 | 838,219,436 |
| 资产总计 | 2,265,618,039.47 | 2,269,214,409.2 | 2,173,831,999.88 | 2,097,352,318.68 |
| 流动负债: | | | | |
| 流动负债合计 | 217,499,020.76 | 241,493,927.19 | 190,325,026 | 162,728,290.74 |
| 非流动负债: | | | | |
| 非流动负债合计 | 21,323,969.09 | 21,012,325.38 | 19,817,215.31 | 20,179,537.92 |
| 负债合计 | 238,822,989.85 | 262,506,252.57 | 210,142,241.31 | 182,907,828.66 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,025,078,541.06 | 2,006,708,156.63 | 1,963,689,758.57 | 1,914,444,490.02 |
| 股东权益合计 | 2,026,795,049.62 | 2,006,708,156.63 | 1,963,689,758.57 | 1,914,444,490.02 |
| 负债和股东权益合计 | 2,265,618,039.47 | 2,269,214,409.2 | 2,173,831,999.88 | 2,097,352,318.68 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 524,820,413.74 | 2,029,025,213.81 | 1,365,179,075.61 | 818,511,410.63 |
| 经营活动现金流出小计 | 513,203,422.89 | 1,717,919,238.58 | 1,236,154,285.54 | 789,702,670.97 |
| 经营活动产生的现金流量净额 | 11,616,990.85 | 311,105,975.23 | 129,024,790.07 | 28,808,739.66 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 140,896,469.42 | 2,779,706,876.94 | 1,910,582,665.43 | 1,278,706,027.34 |
| 投资活动现金流出小计 | 105,529,660.79 | 3,113,500,067.4 | 2,148,677,519.73 | 1,315,871,578.61 |
| 投资活动产生的现金流量净额 | 35,366,808.63 | -333,793,190.46 | -238,094,854.3 | -37,165,551.27 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 45,774,000 | 47,548,000 | 47,548,000 | 23,774,000 |
| 筹资活动现金流出小计 | 57,789,632.37 | 106,573,882.56 | 106,335,725.04 | 82,325,386.01 |
| 筹资活动产生的现金流量净额 | -12,015,632.37 | -59,025,882.56 | -58,787,725.04 | -58,551,386.01 |
| 汇率变动对现金及现金等价物的影响 | -4,214,952.37 | 333,651.31 | 7,013,825.83 | 7,497,128.96 |
| 现金及现金等价物净增加额 | 30,753,214.74 | -81,379,446.48 | -160,843,963.44 | -59,411,068.66 |
| 期末现金及现金等价物余额 | 269,395,115.67 | 238,641,900.93 | 159,177,383.97 | 260,610,278.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -81,379,446.48 | - | -59,411,068.66 |